SERPINF1 and Obesity: In this regard, adipokines, i.e., PEDF and chemerin, may provide a metabolic link between obesity and RA or other autoimmune diseases, and as such they could be possible biomarkers of the effect of weight loss and of the decreased fat tissue in chronic inflammatory diseases.